Tumor microenvironment signals (TME signals)

Tumor microenvironment (TME) signals represent a complex and heterogeneous array of biochemical and physical cues rather than a single molecular target. These signals originate from a variety of sources within the tumor niche, including cancer cells, infiltrating immune cells (such as T cells and macrophages), cancer-associated fibroblasts, and the extracellular matrix. Key components include cytokines like IL-6, growth factors such as VEGF and TGF-beta, and metabolic signals like hypoxia and acidic pH, all of which collaboratively drive tumor progression, metastasis, and therapeutic resistance. In the context of drug development, specific pathways within the TME are targeted to overcome immune suppression or inhibit the vascularization required for tumor growth. However, because 'Tumor microenvironment signals' is an umbrella term for many distinct pathways, it is considered too broad to be classified as a singular therapeutic target.

Other names

Tumor microenvironment factorsStroma-derived signalsTME signaling moleculesCancer-associated signals

Inhibition of specific ligands or receptors within the tumor microenvironment to disrupt pro-tumorigenic signaling, such as blocking VEGF for anti-angiogenesis or PD-1/PD-L1 for immune checkpoint blockade.